Lipella Pharmaceuticals Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Lipella Pharmaceuticals Inc. (LIPO) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 361.62 thousand shares as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2025-11-14
- 2025-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 361.62K shares.
- 2025-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 361.62K shares.
- 2025-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 361.62K shares.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 361.62K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable as first filed |
|---|---|---|
| 2025-09-30 | 361.62K shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 361.62K shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 361.62K shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 361.62K shares 10-Q · filed 2025-11-14 | |
| 2024-09-30 | 343.29K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 2.49M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 2.35M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 284.04K shares 10-K · filed 2025-03-28 | 2.27M shares 10-K · filed 2024-02-27 |
| 2023-09-30 | 2.19M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 2.19M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 1.69M shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 1.62M shares 10-K · filed 2024-02-27 | |
| 2021-12-31 | 1.36M shares 10-K · filed 2023-03-31 |